IR

Israel Rollins, NACD.DC

Venture Capital | Private Equity | Private Company Director | CEO | Founder | Clinical Pharmacist | Investor Relations | Harvard MPA | Kauffman Fellow | NACD Directorship Certified

📍 United States🔄 Updated October 2026💼 6 investments📅 5 years investing🗓 Last invested Dec 2025
VC🌍 United StatesInvested this year
6
Total investments
0
Early stage
3
Mid stage
0
Late stage
5y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Dec 2025
Aikium is revolutionizing therapeutics with Yotta-ML², the world’s first AI-driven trillion-protein screening platform. By unlocking undruggable targets where antibodies and small molecules fail, Aikium pioneers next-generation protein therapeutics for cancer, immune disorders, and beyond—pushing the boundaries of AI-powered drug discovery.
Seed Investor
Mar 2024
The familys healthcare home.
Seed Investor
Feb 2024
Fullsteam Health provides automated data curation services for the worlds leading health systems data teams. Our solution automates the process of data extraction, normalization, concept grouping, thorough data quality monitoring, and effective data consumption into desired workflows. These comprehensive services are utilized by large-scale healthcare organizations to enhance decision-making, improve patient outcomes, and streamline operations. We specialize in preparing health systems for the integration of advanced technologies, such as AI, machine learning, and Large Language Models (LLMs) by optimizing their data infrastructure, ensuring readiness for development and deployment of these applications. For more information, visit fullsteamhealth.com.
Seed Investor
Mar 2023
Our on-demand activation technology is the foundation of interactive films, packaging, and devices that address today problems and build a solution for tomorrow.
Board Observer
Oct 2021
Ultromics pioneers precision heart failure detection. Our groundbreaking platform, EchoGo®, is revolutionizing the diagnosis of heart failure using artificial intelligence and cardiac ultrasound. Our technology empowers clinicians to make precise, efficient, and accurate assessments, drawing from the largest known heart disease dataset in echocardiography. We target challenging cardiac diseases, starting with HFpEF, to support timely diagnosis and early intervention. In collaboration with the Mayo Clinic, Johnson & Johnson, and Pfizer, we are continuously developing innovative diagnostic tools aimed at halting the progression of heart failure. Learn more: https://www.ultromics.com/. Follow Ultromics on social media for the latest news, X: https://x.com/ultromics, LinkedIn: https://www.linkedin.com/company/ultromics/.
Experience · 12 entries
All (12)
Investments (6)
Founder (1)
Board (2)
2026
Founder
Mar 2026
BoardKit™ is the governance operating system for private company boards. Nine professional-grade templates structure the full governance cycle — from meeting preparation through board composition — with embedded compliance verifications, cybersecurity oversight, and governance probes drawn from billion-dollar failures. Built by a healthcare executive and venture investor who served inside one of the most consequential governance crises in American healthcare history. NACD-certified director. Kauffman Fellow. Clinical pharmacist. Medical device CEO with FDA approvals. We built BoardKit for the directors who take the job seriously. For startups, growth-stage ventures, PE-backed operators — because that is where governance matters most and exists least.
2025
Seed Investor
Dec 2025
Aikium is revolutionizing therapeutics with Yotta-ML², the world’s first AI-driven trillion-protein screening platform. By unlocking undruggable targets where antibodies and small molecules fail, Aikium pioneers next-generation protein therapeutics for cancer, immune disorders, and beyond—pushing the boundaries of AI-powered drug discovery.
2024
Board Member
Jul 2024
Renewal House provides long-term comprehensive addiction treatment and recovery programs for women and their children. We address the unique needs and specific issues that contribute to and affect a women’s addiction. We believe when you treat and heal the whole person, you restore a life that can leave a positive lasting legacy.
Seed Investor
Mar 2024
The familys healthcare home.
Seed Investor
Feb 2024
Fullsteam Health provides automated data curation services for the worlds leading health systems data teams. Our solution automates the process of data extraction, normalization, concept grouping, thorough data quality monitoring, and effective data consumption into desired workflows. These comprehensive services are utilized by large-scale healthcare organizations to enhance decision-making, improve patient outcomes, and streamline operations. We specialize in preparing health systems for the integration of advanced technologies, such as AI, machine learning, and Large Language Models (LLMs) by optimizing their data infrastructure, ensuring readiness for development and deployment of these applications. For more information, visit fullsteamhealth.com.
Show all 12 entries ↓
Investment activity
2021–2025 · 6 investments
20211202312024320251
Recent (last 2 years)Earlier